ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

121 - 140 out of 1,009 results.

SCIESCOPUS
A phase 2 study of the oral vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, rivoceranib, for recurrent or metastatic (R/M) adenoid cystic carcinoma (ACC).

Kang, H[Kang, Hyunseok]; Ahn, MJ[Ahn, Myung-Ju]; Muzaffar, J[Muzaffar, Jameel]; Keam, B[Keam, Bhumsuk]; Bowles, DW[Bowles, Daniel W.]; Wong, DJL[Wong, Deborah J. L.]; Ho, AL[Ho, Alan Loh]; Kim, SB[Kim, Sung-Bae]; Worden, FP[Worden, Francis P.]; Yun, T[Yun, Tak], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Alpelisib (ALP) plus endocrine therapy (ET) in patients (pts) with hormone receptorpositive (HR plus ), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated (mut) advanced breast cancer (ABC): Baseline biomarker analysis and progression-free survival (PFS) by duration of prior cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) therapy in the BYLieve study.

Dejan, J[Dejan, Juric]; Rugo, HS[Rugo, Hope S.]; Chia, SKL[Chia, Stephen K. L.]; Lerebours, F[Lerebours, Florence]; Ruiz-Borrego, M[Ruiz-Borrego, Manuel]; Drullinsky, P[Drullinsky, Pamela]; Ciruelos, EM[Ciruelos, Eva M.]; Neven, P[Neven, Patrick]; Park, YH[Park, Yeon Hee]; Arce, CH[Arce, Christina H.], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Diversity, inclusion, and patient (pt)-centricity in the randomized, double-blind, phase III ASTEFANIA study of ado-trastuzumab emtansine (T-DM1) +/- atezolizumab in pts with HER2-positive early breast cancer (EBC) with residual invasive disease after preoperative chemotherapy and anti-HER2 therapy.

Rogerson, S[Rogerson, Sarah]; Turner, H[Turner, Howard]; Bilkhu, A[Bilkhu, Angela]; Monturus, E[Monturus, Estefania]; Knott, A[Knott, Adam]; Restuccia, E[Restuccia, Eleonora]; Quashie, N[Quashie, Nigel]; Wheatley, D[Wheatley, Duncan]; Gilham, L[Gilham, Leslie]; Hurvitz, SA[Hurvitz, Sara A.], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Longterm outcomes from JAVELIN Bladder 100 in subgroups defined by response to 1L chemotherapy.

Perez-Valderrama, B[Perez-Valderrama, Begona]; Powles, T[Powles, Thomas]; Sridhar, SS[Sridhar, Srikala S.]; Caserta, C[Caserta, Claudia]; Loriot, Y[Loriot, Yohann]; Gupta, S[Gupta, Shilpa]; Bellmunt, J[Bellmunt, Joaquim]; Sternberg, CN[Sternberg, Cora N.]; Wang, J[Wang, Jing]; Costa, N[Costa, Nuno], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Observer performance study to examine the feasibility of the AI-powered PD-L1 analyzer to assist pathologists' assessment of PD-L1 expression using tumor proportion score in non-small cell lung cancer.

Kim, S[Kim, Seokhwi]; Kim, H[Kim, Hyojin]; Jung, W[Jung, Wonkyung]; Cho, SI[Cho, Soo Ick]; Bentz, J[Bentz, Joel]; Clingan, W[Clingan, Warren]; Golden, K[Golden, Kevin]; Arcega, R[Arcega, Ramir]; Bae, H[Bae, Hyunsik]; Butler, DL[Butler, Dawn L.], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Phase II study of trastuzumab-pkrb and docetaxel anhydrous combination therapy in recurrent or metastatic salivary ductal carcinomas (KCSG HN18-08/KM11).

Lee, J[Lee, Jiyun]; Park, S[Park, Sehhoon]; Jung, HA[Jung, Hyun Ae]; Lee, SH[Lee, Se-Hoon]; Seo, S[Seo, Seyoung]; Kim, SB[Kim, Sung-Bae]; Kim, JW[Kim, Ji-Won]; Lee, KW[Lee, Keun Wook]; Kang, EJ[Kang, Eun Joo]; Kim, JW[Kim, Ju Won], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Artificial intelligence (AI)-powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of response to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC).

Lee, HJ[Lee, Hee Jin]; Cho, SY[Cho, Soo Yoon]; Cho, EY[Cho, Eun Yoon]; Lim, Y[Lim, Yoojoo]; Cho, SI[Cho, Soo Ick]; Jung, W[Jung, Wonkyung]; Song, S[Song, Sanghoon]; Kang, M[Kang, Mingu]; Ryu, J[Ryu, Jeongun]; Ma, M[Ma, Minuk], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Integrative analysis of plasma cell-free DNA fragmentation and methylation patterns for colorectal cancer detection.

Shin, S[Shin, Seungho]; Jo, SS[Jo, Shin-Sang]; Charton, C[Charton, Clementine]; Kim, S[Kim, Stephanie]; Lim, H[Lim, Hyeyeun]; Kim, SY[Kim, Sol-Yi]; Chung, J[Chung, Jongsuk]; Hong, HK[Hong, Hye Kyung]; Cho, YB[Cho, Yong Beom]; Kim, J[Kim, Jinho], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Comprehensive landscape of tumor angiogenesis via integrating RNA sequencing and three-dimensional microphysiological system.

Ko, J[Ko, Jihoon]; Hyung, S[Hyung, Sujin]; An, M[An, Minae]; Park, SH[Park, Se Hoon]; Kim, ST[Kim, Seung Tae]; Kang, W[Kang, Wonki]; Jeon, NL[Jeon, Noo Li]; Lee, J[Lee, Jeeyun]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16, pp.E16058 - E16058PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Genetic counselling and testing for breast and ovarian cancer in Asia: A multinational survey of unmet needs.

Kwong, A[Kwong, Ava]; Tan, DSP[Tan, David Shao Peng]; Ryu, JM[Ryu, Jai Min]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Event-free survival by residual cancer burden after neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for early TNBC: Exploratory analysis from KEYNOTE-522.

Pusztai, L[Pusztai, Lajos]; Denkert, C[Denkert, Carsten]; O'Shaughnessy, J[O'Shaughnessy, Joyce]; Cortes, J[Cortes, Javier]; Dent, RA[Dent, Rebecca Alexandra]; McArthur, HL[McArthur, Heather L.]; Kuemmel, S[Kuemmel, Sherko]; Bergh, JCS[Bergh, Jonas C. S.]; Park, YH[Park, Yeon Hee]; Hui, RN[Hui, Rina], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Amivantamab and lazertinib in patients with EGFR-mutant non-small cell lung (NSCLC) after progression on osimertinib and platinum-based chemotherapy: Updated results from CHRYSALIS-2.

Shu, CA[Shu, Catherine A.]; Goto, K[Goto, Koichi]; Ohe, Y[Ohe, Yuichiro]; Besse, B[Besse, Benjamin]; Lee, SH[Lee, Se-Hoon]; Wang, YS[Wang, Yongsheng]; Griesinger, F[Griesinger, Frank]; Yang, JCH[Yang, James Chih-Hsin]; Felip, E[Felip, Enriqueta]; Sanborn, RE[Sanborn, Rachel E.], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Clinical efficacy of laparoscopic sentinel node navigation surgery for early gastric cancer: Five-year results of SENORITA trial.

Hur, H[Hur, Hoon]; Lee, YJ[Lee, Young Joon]; Kim, YW[Kim, Young-Woo]; Min, JS[Min, Jae-Seok]; Yoon, HM[Yoon, Hong Man]; An, JY[An, Ji Yeong]; Eom, BW[Eom, Bang Wool]; Cho, GS[Cho, Gyu Seok]; Park, YK[Park, Young-Kyu]; Jung, MR[Jung, Mi Ran], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
ARTISTRY-6: Nemvaleukin alfa monotherapy in patients with advanced mucosal and cutaneous melanoma.

Weber, JS[Weber, Jeffrey S.]; Carvajal, RD[Carvajal, Richard D.]; Hamid, O[Hamid, Omid]; Kim, ST[Kim, Seung Tae]; Kim, M[Kim, Miso]; Sullivan, RJ[Sullivan, Ryan J.]; Lee, DH[Lee, Dae Ho]; Mehmi, I[Mehmi, Inderjit]; Grewal, JS[Grewal, Jaspreet Singh]; Lee, HJ[Lee, Hyo Jin], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A randomized, prospective, multicenter trial of 3D printing, a patient-specific surgical guide for breast-conserving surgery after neoadjuvant chemotherapy: Comparative evaluation according to the presence or absence of surgical guide.

Kim, HK[Kim, Hong-Kyu]; Ryu, JM[Ryu, Jai Min]; Ahn, SH[Ahn, Sei-Hyun]; Kim, J[Kim, Jeeye]; Son, BH[Son, Byung Ho]; Kim, HH[Kim, Hak-Hee]; Lee, JE[Lee, Jeong Eon]; Chae, BJ[Chae, Byung-Joo]; Lee, HB[Lee, Han-Byoel]; Ahn, JH[Ahn, Jee Hyun], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Phase 2 study of tarlatamab, a DLL3-targeting, half life-extended, bispecific T-cell engager (HLE BiTE) immuno-oncology therapy, in relapsed/refractory small cell lung cancer (SCLC).

Ramalingam, SS[Ramalingam, Suresh S.]; Ahn, MJ[Ahn, Myung-Ju]; Akamatsu, H[Akamatsu, Hiroaki]; Blackhall, FH[Blackhall, Fiona Helen]; Borghaei, H[Borghaei, Hossein]; Hummel, HD[Hummel, Horst-Dieter]; Johnson, ML[Johnson, Melissa Lynne]; Reck, M[Reck, Martin]; Zhang, Y[Zhang, Yiran]; Jandial, D[Jandial, Danielle], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Global multi-center phase I trial of the intraperitoneal infusion of anti-EpCAM x anti-CD3 bispecific antibody catumaxomab for advanced gastric carcinoma with peritoneal metastasis.

Qi, CS[Qi, Changsong]; Wu, SK[Wu, Shikai]; Kim, IH[Kim, In-Ho]; Cai, SR[Cai, Shirong]; Wang, JF[Wang, Jufeng]; Kim, ST[Kim, Seung Tae]; Wang, JY[Wang, Jaw-Yuan]; Bai, LY[Bai, Li-Yuan]; Lin, CY[Lin, Cheng-Yao]; Liang, ZZ[Liang, Zhezhao], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16, pp.E16102 - E16102PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Zanidatamab (zani), a HER2-targeted bispecific antibody, in combination with docetaxel as first-line (1L) therapy for patients (pts) with advanced HER2-positive breast cancer: Preliminary results from a phase 1b/2 study.

Lee, KS[Lee, Keun-Seok]; Wang, XJ[Wang, Xiaojia]; Im, YH[Im, Young Hyuck]; Zeng, XH[Zeng, Xiaohua]; Li, HP[Li, Huiping]; Wang, K[Wang, Kun]; Li, HY[Li, Huiyan]; Zhou, P[Zhou, Ping]; Bao, YY[Bao, Yuanyuan]; Jiang, ZF[Jiang, Zefei]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping.

Kato, T[Kato, Terufumi]; Yang, JCH[Yang, James Chih-Hsin]; Ahn, MJ[Ahn, Myung-Ju]; Sakai, H[Sakai, Hiroshi]; Morise, M[Morise, Masahiro]; Chen, YM[Chen, Yuh-Min]; Han, JY[Han, Ji-Youn]; Yang, JJ[Yang, Jin-Ji]; Zhao, J[Zhao, Jun]; Huang, J[Huang, Jason], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
First-line brentuximab vedotin plus chemotherapy to improve overall survival in patients with stage III/IV classical Hodgkin lymphoma: An updated analysis of ECHELON-1.

Ansell, SM[Ansell, Stephen M.]; Connors, JM[Connors, Joseph M.]; Radford, JA[Radford, John A.]; Kim, WS[Kim, Won Seog]; Gallamini, A[Gallamini, Andrea]; Ramchandren, R[Ramchandren, Radhakrishnan]; Friedberg, JW[Friedberg, Jonathan W.]; Advani, RH[Advani, Ranjana H.]; Hutchings, M[Hutchings, Martin]; Evens, AM[Evens, Andrew M.], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
1 2 3 4 5 6 7 8 9 10 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어